Next Generation Tools for Genomic Data Generation, Distribution, and Visualization

Por Nix, D.A.
Publicado em 2010

Pharmacodynamics of metronidazole determined by a time-kill assay for Trichomonas vaginalis.

Por Nix, D E, Tyrrell, R, Müller, M
Publicado em 1995

Effect of lomefloxacin on theophylline pharmacokinetics.

Por Nix, D E, Norman, A, Schentag, J J
Publicado em 1989

Characterization of a Rhodospirillum rubrum plasmid: loss of photosynthetic growth in plasmidless strains.

Por Kuhl, S A, Nix, D W, Yoch, D C
Publicado em 1983

Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection.

Por Oh, Y K, Nix, D E, Straubinger, R M
Publicado em 1995

In vitro selection of resistant Helicobacter pylori.

Por Haas, C E, Nix, D E, Schentag, J J
Publicado em 1990

New turbidimetric assay for quantitation of viable bacterial densities.

Por Li, R C, Nix, D E, Schentag, J J
Publicado em 1993

The fractional maximal effect method: a new way to characterize the effect of antibiotic combinations and other nonlinear pharmacodynamic interactions.

Por Li, R C, Schentag, J J, Nix, D E
Publicado em 1993

Pharmacokinetic and pharmacodynamic activities of ciprofloxacin against strains of Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are si...

Por Hyatt, J M, Nix, D E, Schentag, J J
Publicado em 1994

Effect of oral antacid administration on the pharmacokinetics of intravenous doxycycline.

Por Nguyen, V X, Nix, D E, Gillikin, S, Schentag, J J
Publicado em 1989

Pharmacokinetics of high-dose intravenous ciprofloxacin in young and elderly and in male and female subjects.

Por Shah, A, Lettieri, J, Nix, D, Wilton, J, Heller, A H
Publicado em 1995

Comparison of two methods for determining in vitro postantibiotic effects of three antibiotics on Escherichia coli.

Por Rescott, D L, Nix, D E, Holden, P, Schentag, J J
Publicado em 1988

In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cl...

Por Hyatt, J M, Nix, D E, Stratton, C W, Schentag, J J
Publicado em 1995

Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin.

Por Forrest, A, Ballow, C H, Nix, D E, Birmingham, M C, Schentag, J J
Publicado em 1993

Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning.

Por Nix, D E, Goodwin, S D, Peloquin, C A, Rotella, D L, Schentag, J J
Publicado em 1991

Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response.

Por Nix, D E, Goodwin, S D, Peloquin, C A, Rotella, D L, Schentag, J J
Publicado em 1991

Inhibition of norfloxacin absorption by antacids.

Por Nix, D E, Wilton, J H, Ronald, B, Distlerath, L, Williams, V C, Norman, A
Publicado em 1990

Effect of oral antacids on disposition of intravenous enoxacin.

Por Nix, D E, Lebsack, M E, Chapelsky, M, Sedman, A J, Busch, J, Norman, A
Publicado em 1993

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.

Por Forrest, A, Nix, D E, Ballow, C H, Goss, T F, Birmingham, M C, Schentag, J J
Publicado em 1993

Treatment of gastrointestinal cytomegalovirus infection with twice-daily foscarnet: a pilot study of safety, efficacy, and pharmacokinetics in patients with AIDS.

Por Dieterich, D T, Poles, M A, Lew, E A, Martin-Munley, S, Johnson, J, Nix, D, Faust, M J
Publicado em 1997